SBIR/STTR Research Award

ALTERNATIVES TO COMMERCIALLY AVAILABLE CELL CULTURE INSERT MEMBRANES AND MANUFACTURING TECHNIQUES (POP:7/27/2020 TO 04/26/2021)

Award identifier b666b60df3d9f6f020a6c6e097ea1d828d84130268634147384f29fffef5a37dAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$225,000

Program and phase

SBIR · Phase I

Award year

2020

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
INNOVATIVE SURFACE TECHNOLOGIES INC
Proposal award date
Not reported
Contract end date
Not reported
UEI
HA96NDV2J3L5
Solicitation number
Not reported
Topic code
19

Research abstract

Cell culture tools expand our abilities to conduct research from studying basic properties to developing specific medical treatments. These tools work best when they reflect cell's and tissue's biological environment as closely as possible while maintaining high reproducibility and functioning well in today's high throughput laboratories. As such, cell culture is moving to 3D tissue models, focusing on their in vivo-like properties as opposed to earlier 2D culture. Degradable membranes are porous and can contain fibrillar structures similar to those found in nature, while also providing structural support to cells. As cells and tissue grow on a membrane, their extracellular matrix can fill the pores and replace the function of the degrading membrane, resulting in a free-standing tissue for experimentation. To that end, biodegradable membranes will be incorporated into a novel cell culture insert with designs that can be automated for manufacture and extended from 6 to 96 well plates or more. Electrospinning will be used to create nanofibrillar membranes of PCL and PLGA, well characterized biodegradable materials. Two designs will be investigated initially with a single cell line, and then subsequently, in a skin cancer tissue model to validate the insert.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

28 SBIR/STTR records share this UEI (2005–2021). Reported award amounts total $11,296,831. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.